Vladutiu A O, Steinman L
Department of Pathology, SUNY at Buffalo, School of Medicine 14203.
Cell Immunol. 1987 Oct 1;109(1):169-80. doi: 10.1016/0008-8749(87)90302-9.
Experimental autoimmune thyroiditis is induced in mice by immunization with thyroglobulin emulsified in Freund's complete adjuvant. The disease is characterized both by thyroid infiltration with mononuclear cells and by circulating thyroglobulin antibodies. The magnitude of the thyroid infiltration and the titer of thyroglobulin antibodies are controlled by genes in the I-A subregion of the major histocompatibility complex (H-2). We investigated the in vivo effect of monoclonal anti-Ia antibodies on experimental autoimmune thyroiditis in susceptible mice. Antibodies were given around the time of immunization, later after immunization, and to mice with established disease. Monoclonal antibody produced by the hybridoma line 10-3.6 (anti-I-Ak, s, u, v, z, f) completely prevented both production of thyroglobulin antibodies and thyroid infiltrates, when given shortly before or at the time of antigen administration. This effect was dose-dependent and this monoclonal antibody decreased the severity of the disease when given after the antigen challenge but did not fully suppress established thyroiditis. The same antibody markedly decreased the number of B lymphocytes in the spleen and decreased the thyroglobulin-induced spleen cell proliferation when either given in vivo or added in vitro to cell cultures. Antibodies produced by the hybridoma line 11.2.12 (anti-I-Ak) did not show an inhibitory effect on the disease. These experiments suggest that in this model of murine thyroiditis anti-Ia antibodies act on antigen-presenting cells. Furthermore, only one monoclonal antibody, anti-Ia, suppressed the immune response to thyroglobulin, suggesting a possible role for the isotype and specificity of anti-Ia antibody.
通过用弗氏完全佐剂乳化的甲状腺球蛋白免疫小鼠可诱发实验性自身免疫性甲状腺炎。该疾病的特征是甲状腺出现单核细胞浸润以及循环甲状腺球蛋白抗体。甲状腺浸润的程度和甲状腺球蛋白抗体的滴度由主要组织相容性复合体(H-2)的I-A亚区中的基因控制。我们研究了单克隆抗Ia抗体对易感小鼠实验性自身免疫性甲状腺炎的体内作用。在免疫时、免疫后一段时间以及对已发病的小鼠给予抗体。由杂交瘤细胞系10-3.6产生的单克隆抗体(抗I-Ak、s、u、v、z、f)在抗原给药前或给药时给予时,完全阻止了甲状腺球蛋白抗体的产生和甲状腺浸润。这种作用是剂量依赖性的,并且该单克隆抗体在抗原攻击后给予时可降低疾病的严重程度,但不能完全抑制已形成的甲状腺炎。相同的抗体在体内给予或体外添加到细胞培养物中时,可显著减少脾脏中B淋巴细胞的数量,并降低甲状腺球蛋白诱导的脾细胞增殖。由杂交瘤细胞系11.2.12产生的抗体(抗I-Ak)对该疾病未显示出抑制作用。这些实验表明,在这种小鼠甲状腺炎模型中,抗Ia抗体作用于抗原呈递细胞。此外,只有一种单克隆抗Ia抗体抑制了对甲状腺球蛋白的免疫反应,提示抗Ia抗体的同种型和特异性可能发挥作用。